UH Cancer Center partners with nation's top cancer centers to endorse goal

Nearly 80 million Americans – one out of every four people – are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the U.S.

University of Hawai’i Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer. These institutions collectively recognize insufficient vaccination as a public health threat and call upon the nations’ physicians, parents and young adults to take advantage of this rare opportunity to eliminate several different types of cancer in men and women.

As a part of this initiative, the UH Cancer conducted a statewide survey of primary care physicians who identified specific barriers to adolescent HPV vaccine uptake. The barriers identified were related to logistics, attitudes and perceptions, as well as the absence of school-based HPV vaccine requirements.

“HPV vaccination remains a powerful tool in the effort to prevent cancers caused by the human papillomavirus in Hawai’i. The


Article originally posted at


Click here for the full story


Privacy Policy / Terms Of Use

       Powered by MMD